Kiadaliri Aliasghar A, Englund Martin
Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Clinical Epidemiology Unit, Lund, Sweden.
Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
BMC Musculoskelet Disord. 2016 Apr 14;17:163. doi: 10.1186/s12891-016-1024-9.
The aim was to assess time trend of mortality with musculoskeletal disorders (MSD) as underlying cause of death in Sweden from 1997 to 2013.
We obtained data on MSD as underlying cause of death across age and sex groups from the National Board of Health and Welfare's Cause of Death Register. Age-standardized mortality rates per million population for all MSD, its six major subgroups, and all other ICD-10 (International Classification of Disease) chapters were calculated. We computed the average annual percent change (AAPC) in the mortality rates across age/sex groups using joinpoint regression analysis by fitting a regression line to the natural logarithm of the age-standardized mortality rates and calendar year as a predictor.
There were a total of 7 976 deaths (0.5% of all causes deaths) with MSD as the underlying cause of death (32.5% of these deaths caused by rheumatoid arthritis [RA]). The overall age-standardized mortality rates (95% CI) were 16.0 (15.4 to 16.7) and 24.9 (24.1 to 25.7) per million among men and women, respectively (women/men rate ratio 1.55; 95%CI 1.47 to 1.63). On average, mortality rate declined by 2.3% per year and only circulatory system mortality had a more favourable decline than mortality with MSD as underlying cause. Among MSD the highest decline was observed in RA (3.7% per year) during study period. Across age groups, while there were generally stable or declining trends, spondylopathies and osteoporosis mortality among people ≥ 75 years increased by 2 and 1.5% per year, respectively.
In overall, mortality with MSD as underlying cause has declined in Sweden over last two decades, with the highest decline for RA. However, there are variations across MSD subgroups which warrants further investigations.
目的是评估1997年至2013年期间,以肌肉骨骼疾病(MSD)作为潜在死因的瑞典死亡率的时间趋势。
我们从国家卫生和福利委员会的死亡原因登记处获取了按年龄和性别分组的以MSD作为潜在死因的数据。计算了所有MSD、其六个主要亚组以及所有其他ICD - 10(国际疾病分类)章节每百万人口的年龄标准化死亡率。我们通过将年龄标准化死亡率的自然对数与日历年作为预测变量进行拟合,使用连接点回归分析计算了各年龄/性别组死亡率的平均年度百分比变化(AAPC)。
共有7976例死亡(占所有死因死亡的0.5%)以MSD作为潜在死因(其中32.5%的死亡由类风湿性关节炎[RA]引起)。男性和女性的总体年龄标准化死亡率(95%CI)分别为每百万16.0(15.4至16.7)和24.9(24.1至25.7)(女性/男性死亡率比为1.55;95%CI为1.47至1.63)。平均而言,死亡率每年下降2.3%,只有循环系统死亡率的下降比以MSD作为潜在死因的死亡率下降更有利。在研究期间,MSD中下降幅度最大的是RA(每年3.7%)。在各年龄组中,虽然总体趋势稳定或下降,但75岁及以上人群的脊椎病和骨质疏松症死亡率分别每年增加2%和1.5%。
总体而言,在过去二十年中,瑞典以MSD作为潜在死因的死亡率有所下降,其中RA下降幅度最大。然而,MSD亚组之间存在差异,值得进一步研究。